IL130697A0 - 3'-N-oxide,3'-N-dimethylamine,9-oxime erythromycin A derivatives - Google Patents

3'-N-oxide,3'-N-dimethylamine,9-oxime erythromycin A derivatives

Info

Publication number
IL130697A0
IL130697A0 IL13069798A IL13069798A IL130697A0 IL 130697 A0 IL130697 A0 IL 130697A0 IL 13069798 A IL13069798 A IL 13069798A IL 13069798 A IL13069798 A IL 13069798A IL 130697 A0 IL130697 A0 IL 130697A0
Authority
IL
Israel
Prior art keywords
dimethylamine
derivatives
oxide
oxime erythromycin
erythromycin
Prior art date
Application number
IL13069798A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL130697A0 publication Critical patent/IL130697A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13069798A 1997-02-13 1998-02-03 3'-N-oxide,3'-N-dimethylamine,9-oxime erythromycin A derivatives IL130697A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,009 US5864023A (en) 1997-02-13 1997-02-13 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
PCT/US1998/001929 WO1998035976A1 (en) 1997-02-13 1998-02-03 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives

Publications (1)

Publication Number Publication Date
IL130697A0 true IL130697A0 (en) 2000-06-01

Family

ID=25177295

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13069798A IL130697A0 (en) 1997-02-13 1998-02-03 3'-N-oxide,3'-N-dimethylamine,9-oxime erythromycin A derivatives

Country Status (25)

Country Link
US (1) US5864023A (bg)
EP (1) EP0966477B1 (bg)
JP (1) JP2001512456A (bg)
KR (1) KR100561326B1 (bg)
CN (1) CN1326865C (bg)
AR (1) AR012032A1 (bg)
AT (1) ATE252108T1 (bg)
AU (1) AU725274B2 (bg)
BG (1) BG64099B1 (bg)
BR (1) BR9807349A (bg)
CA (1) CA2279932C (bg)
CZ (1) CZ294481B6 (bg)
DE (1) DE69818977T2 (bg)
DK (1) DK0966477T3 (bg)
ES (1) ES2212266T3 (bg)
HU (1) HUP0001330A3 (bg)
IL (1) IL130697A0 (bg)
NO (1) NO993876D0 (bg)
NZ (1) NZ336482A (bg)
PL (1) PL187357B1 (bg)
PT (1) PT966477E (bg)
SK (1) SK284157B6 (bg)
TR (1) TR199901874T2 (bg)
WO (1) WO1998035976A1 (bg)
ZA (1) ZA98986B (bg)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
EP1254146B1 (en) * 1999-12-16 2005-08-24 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs and novel polymorph iv
PT1280535E (pt) * 2000-01-11 2005-04-29 Teva Pharma Processos para a preparacao de polimorfos de claritromicina
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
CA2401571A1 (en) * 2000-02-29 2001-09-07 Ilya Avrutov Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
BR0109194A (pt) * 2000-03-15 2003-02-11 Hanmi Pharm Ind Co Ltd Método para preparar claritromicina em cristais da forma ii
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 ａ의 제조방법
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
JP2006528189A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
EP1648407A4 (en) * 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
WO2005009364A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653925A1 (en) * 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1658034A4 (en) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2538064C (en) * 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US7694523B2 (en) * 2004-07-19 2010-04-13 Earthrenew, Inc. Control system for gas turbine in material treatment unit
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
EP0254534A3 (en) * 1986-07-24 1991-04-17 William S. Robinson Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharmaceutical Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法

Also Published As

Publication number Publication date
BR9807349A (pt) 2000-04-25
CN1326865C (zh) 2007-07-18
DE69818977T2 (de) 2004-08-12
KR100561326B1 (ko) 2006-03-16
JP2001512456A (ja) 2001-08-21
DE69818977D1 (en) 2003-11-20
WO1998035976A1 (en) 1998-08-20
CA2279932A1 (en) 1998-08-20
CZ294481B6 (cs) 2005-01-12
AU725274B2 (en) 2000-10-12
PT966477E (pt) 2004-03-31
SK284157B6 (sk) 2004-10-05
NO993876L (no) 1999-08-11
HUP0001330A2 (hu) 2000-08-28
AU6260898A (en) 1998-09-08
EP0966477A1 (en) 1999-12-29
NZ336482A (en) 2001-02-23
BG103673A (bg) 2000-02-29
AR012032A1 (es) 2000-09-27
CZ270499A3 (cs) 1999-11-17
KR20000070985A (ko) 2000-11-25
PL335301A1 (en) 2000-04-10
TR199901874T2 (xx) 2000-04-21
ZA98986B (en) 1998-08-05
HUP0001330A3 (en) 2000-09-28
CN1246864A (zh) 2000-03-08
ES2212266T3 (es) 2004-07-16
EP0966477B1 (en) 2003-10-15
NO993876D0 (no) 1999-08-11
ATE252108T1 (de) 2003-11-15
SK97499A3 (en) 2000-01-18
PL187357B1 (pl) 2004-06-30
US5864023A (en) 1999-01-26
BG64099B1 (bg) 2003-12-31
DK0966477T3 (da) 2004-02-23
CA2279932C (en) 2008-04-22

Similar Documents

Publication Publication Date Title
IL130697A0 (en) 3'-N-oxide,3'-N-dimethylamine,9-oxime erythromycin A derivatives
ZA985018B (en) 9-oxime erythromycin derivatives.
HK1028048A1 (en) 4"-Substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives.
ZA985016B (en) C-4"-substituted macrolide derivatives.
IL136721A0 (en) Novel erythromycin derivatives
ZA9710648B (en) Erythromycin A derivatives.
ZA987688B (en) 6,9-bridged erythromycin derivatives
IL134996A0 (en) 6,11-bridged erythromycin derivatives
HU9802807D0 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives
ZA989835B (en) Erythromycin a derivatives
ZA989830B (en) Erythromycin a derivatives
AU6421398A (en) Erythromycin a derivatives
NZ297446A (en) Erythromycin a 9-0-oximes; medicaments
AU9646098A (en) Erythromycin a derivatives
IL124084A0 (en) Erythromycin a derivatives and methods for the preparation thereof
ZA981572B (en) Erythromycin a derivatives
ZA983902B (en) Erythromycin derivatives.
EP1044985A4 (en) ERYTHROMYCIN DERIVATIVES
ZA978546B (en) Erythromycin A derivatives.
AU4472797A (en) Erythromycin a derivatives
SI0966477T1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
AU4472697A (en) Erythromycin a derivatives
ZA989848B (en) 6,11-bridged erythromycin derivatives
SI1027361T1 (en) 6,11-bridged erythromycin derivatives
SI1015467T1 (en) 6,9-bridged erythromycin derivatives